{"doi":"10.1128/aac.01956-19","title":"Early Bactericidal Activity Trial of Nitazoxanide for Pulmonary Tuberculosis","abstract":"This study was conducted in treatment-naive adults with drug-susceptible pulmonary tuberculosis in Port-au-Prince, Haiti, to assess the safety, bactericidal activity, and pharmacokinetics of nitazoxanide (NTZ). This was a prospective phase II clinical trial in 30 adults with pulmonary tuberculosis. Twenty participants received 1 g of NTZ orally twice daily for 14 days. A control group of 10 participants received standard therapy over 14 days. The primary outcome was the change in time to culture positivity (TTP) in an automated liquid culture system.","journal":"Antimicrobial Agents and Chemotherapy","year":2020,"id":98314,"datarank":1.0866026801876298,"base_score":3.4657359027997265,"endowment":3.4657359027997265,"self_citation_contribution":0.519860385419959,"citation_network_contribution":0.5667422947676709,"self_endowment_contribution":0.519860385419959,"citer_contribution":0.5667422947676709,"corpus_percentile":null,"corpus_rank":null,"citation_count":31,"citer_count":25,"citers_with_citation_signal":21,"citers_with_endowment":21,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9491,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT02684240"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":485847,"name":"Katherine McAulay","orcid":null,"position":1,"is_corresponding":false},{"id":485848,"name":"Miroku Lee","orcid":null,"position":2,"is_corresponding":false},{"id":325516,"name":"Stalz Charles Vilbrun","orcid":"0009-0002-9482-1725","position":3,"is_corresponding":false},{"id":482168,"name":"L Mathurin","orcid":null,"position":4,"is_corresponding":false},{"id":485849,"name":"Daphie Francois","orcid":null,"position":5,"is_corresponding":false},{"id":485850,"name":"M J Zimmerman","orcid":null,"position":6,"is_corresponding":false},{"id":458979,"name":"Firat Kaya","orcid":"0000-0001-8655-2065","position":7,"is_corresponding":false},{"id":485851,"name":"Na-Na Zhang","orcid":null,"position":8,"is_corresponding":false},{"id":308260,"name":"Kohta Saito","orcid":"0000-0002-2190-4127","position":9,"is_corresponding":false},{"id":485092,"name":"Oksana Ocheretina","orcid":"0000-0002-6736-3362","position":10,"is_corresponding":false},{"id":455381,"name":"Radojka M. Savić","orcid":"0000-0003-3143-5579","position":11,"is_corresponding":false},{"id":283116,"name":"Véronique Dartois","orcid":"0000-0001-9470-5009","position":12,"is_corresponding":false},{"id":485093,"name":"William D. Johnson","orcid":"0000-0002-3823-4094","position":13,"is_corresponding":false},{"id":325512,"name":"Jean W. Pape","orcid":"0000-0002-2948-2774","position":14,"is_corresponding":false},{"id":111358,"name":"Carl F. Nathan","orcid":"0000-0002-7744-8896","position":15,"is_corresponding":false},{"id":380456,"name":"Daniel W. Fitzgerald","orcid":"0000-0003-1765-0598","position":16,"is_corresponding":false},{"id":111352,"name":"Kathleen Frances Walsh","orcid":"0000-0002-9001-3918","position":0,"is_corresponding":true}],"reference_count":20,"raw_metadata":null,"created_at":"2026-07-18T22:36:34.157932Z","pmid":"32071052","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}